Your browser doesn't support javascript.
loading
Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag.
Stucke, Emily M; Niangaly, Amadou; Berry, Andrea A; Bailey, Jason A; Coulibaly, Drissa; Ouattara, Amed; Lyke, Kirsten E; Laurens, Matthew B; Dara, Antoine; Adams, Matthew; Pablo, Jozelyn; Jasinskas, Algis; Nakajima, Rie; Zhou, Albert E; Agrawal, Sonia; Friedman-Klabanoff, DeAnna J; Takala-Harrison, Shannon; Kouriba, Bourema; Kone, Abdoulaye K; Rowe, J Alexandra; Doumbo, Ogobara K; Felgner, Philip L; Thera, Mahamadou A; Plowe, Christopher V; Travassos, Mark A.
Afiliación
  • Stucke EM; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Niangaly A; Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Berry AA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Bailey JA; The EMMES Corporation, Rockville, MD, USA.
  • Coulibaly D; Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Ouattara A; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Lyke KE; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Laurens MB; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Dara A; Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Adams M; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Pablo J; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, CA, USA.
  • Jasinskas A; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, CA, USA.
  • Nakajima R; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, CA, USA.
  • Zhou AE; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Agrawal S; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Friedman-Klabanoff DJ; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Takala-Harrison S; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Kouriba B; Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Kone AK; Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Rowe JA; Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, UK.
  • Doumbo OK; Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Felgner PL; Division of Infectious Diseases, Department of Medicine, University of California, Irvine, CA, USA.
  • Thera MA; Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Plowe CV; Duke Global Health Institute, Duke University, Durham, NC, USA.
  • Travassos MA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. mtravass@som.umaryland.edu.
Malar J ; 18(1): 273, 2019 Aug 13.
Article en En | MEDLINE | ID: mdl-31409360
ABSTRACT

BACKGROUND:

Plasmodium falciparum erythrocyte membrane protein-1 (PfEMP1) antigens play a critical role in host immune evasion. Serologic responses to these antigens have been associated with protection from clinical malaria, suggesting that antibodies to PfEMP1 antigens may contribute to natural immunity. The first N-terminal constitutive domain in a PfEMP1 is the Duffy binding-like alpha (DBL-α) domain, which contains a 300 to 400 base pair region unique to each particular protein (the DBL-α "tag"). This DBL-α tag has been used as a marker of PfEMP1 diversity and serologic responses in malaria-exposed populations. In this study, using sera from a malaria-endemic region, responses to DBL-α tags were compared to responses to the corresponding entire DBL-α domain (or "parent" domain) coupled with the succeeding cysteine-rich interdomain region (CIDR).

METHODS:

A protein microarray populated with DBL-α tags, the parent DBL-CIDR head structures, and downstream PfEMP1 protein fragments was probed with sera from Malian children (aged 1 to 6 years) and adults from the control arms of apical membrane antigen 1 (AMA1) vaccine clinical trials before and during a malaria transmission season. Serological responses to the DBL-α tag and the DBL-CIDR head structure were measured and compared in children and adults, and throughout the season.

RESULTS:

Malian serologic responses to a PfEMP1's DBL-α tag region did not correlate with seasonal malaria exposure, or with responses to the parent DBL-CIDR head structure in either children or adults. Parent DBL-CIDR head structures were better indicators of malaria exposure.

CONCLUSIONS:

Larger PfEMP1 domains may be better indicators of malaria exposure than short, variable PfEMP1 fragments such as DBL-α tags. PfEMP1 head structures that include conserved sequences appear particularly well suited for study as serologic predictors of malaria exposure.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Proteínas Protozoarias / Malaria Falciparum / Antígenos de Protozoos Tipo de estudio: Prognostic_studies Límite: Adult / Child / Child, preschool / Humans / Infant / Middle aged Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Proteínas Protozoarias / Malaria Falciparum / Antígenos de Protozoos Tipo de estudio: Prognostic_studies Límite: Adult / Child / Child, preschool / Humans / Infant / Middle aged Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos